Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Another DePuy ASR Lawsuit Settles Right Before Trial Set to Begin October 16, 2013 Irvin Jackson Add Your Comments It appears that Johnson & Johnson’s DePuy Orthopaedics subsidiary has agreed to settle another lawsuit over their recalled ASR hip replacement, once again reaching a resolution only days before trial was scheduled to begin. Nearly 12,000 DePuy ASR lawsuits are pending in state and federal courts throughout the country involving allegations that design defects with the metal-on-metal hip replacement increased the risk that users would experience problems with their artificial hip within a few years after it is implanted. DePuy recalled their ASR hip implanted in August 2010, amid reports that suggested a higher-than-expected number were failing during the first five years. As the first trials approach in state and federal courts, at least two case have now resolved for undisclosed amounts. Stay Up-to-Date About hip replacement lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new hip replacement lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Hip Replacement Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new hip replacement lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More A complaint filed by Debora MacDonald was scheduled for trial to begin on October 21 in New Jersey state court, where cases are centralized for coordinated proceedings as part of an MCL or Multi-County Litigation. According to a Case Management Order (PDF) issued by New Jersey Judge Brian R. Martinotti, the parties have informed the court that the MacDonald case “has been resolved,” resulting in the cancellation of the upcoming trial date. Earlier this month, a similar DePuy ASR settlement agreement was reported in California state court, where a complaint filed by Robert Eugene Ottman was also set for trial to begin in late October. Details have not been reported for the terms of either settlement. DePuy ASR Settlement Negotiations and Early Trials Prior reports have suggested that Johnson & Johnson was considering an offer of more than $3 billion to settle the DePuy ASR litigation, which would average out to about $300,000 per case. According to a report by Bloomberg News in January 2013, plaintiffs previously rejected an offer that averaged about $200,000 per case because it did not provide sufficient compensation for injuries caused by the recalled hip implant. While thousands of cases are pending, a small number of lawsuits have been set for early trial dates in state and federal courts to help the parties gauge how juries are likely to respond to certain evidence and testimony that may be repeated throughout a large number of claims. Earlier this year, a California jury awarded $8.3 million in damages in one case. However, a second trial held in Illinois state court resulted in a defense verdict for the manufacturer. In the federal court system, all DePuy ASR lawsuits are consolidated for pretrial proceedings before U.S. District Judge David A. Katz in the Northern District of Ohio, where the first “bellwether” trials are expected to begin in January 2014. That case was originally set to begin in September, but has been postponed at least two times, leading to speculation that the parties may be considering a settlement. In New Jersey state court, the next DePuy ASR trial is also expected to begin in January 2014, involving a consolidated trial for two different individuals who have experienced similar problems following DePuy hip replacement surgery. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Depuy ASR Hip, DePuy Hip Replacement, Johnson & Johnson, Metal Hip Replacement, New Jersey More DePuy ASR Hip Lawsuit Stories Biomet Hip Lawsuit Filed Over Defective M2A Metal-on-Metal Implant December 26, 2024 Zimmer Biomet Lawsuit Filed Over RibFix Blu Implant Fracture September 25, 2024 Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024 0 Comments X/TwitterThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (Posted: today) A federal judge has given the makers of Dupixent until January 7 to respond to a Tennessee woman’s wrongful death lawsuit. MORE ABOUT: DUPIXENT LAWSUITDupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025) Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: yesterday) A federal judge has scheduled a series of case management conferences throughout 2026 as the parties prepare for five “pilot” bellwether trials, which are expected to begin in late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)Depo-Provera Pilot Lawsuit Deadlines in MDL Extended Approximately 6 Weeks (11/04/2025) Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 6 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024
Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (Posted: today) A federal judge has given the makers of Dupixent until January 7 to respond to a Tennessee woman’s wrongful death lawsuit. MORE ABOUT: DUPIXENT LAWSUITDupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025)
Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: yesterday) A federal judge has scheduled a series of case management conferences throughout 2026 as the parties prepare for five “pilot” bellwether trials, which are expected to begin in late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)Depo-Provera Pilot Lawsuit Deadlines in MDL Extended Approximately 6 Weeks (11/04/2025)
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 6 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)